Acerus Pharmaceuticals (ASPCF) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ASPCF Stock Alerts $0.22 0.00 (0.00%) (As of 07/21/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAcerus Announces Commencement of Court-Approved Sale and Investment Solicitation Processfinance.yahoo.com - March 14 at 7:52 AMAcerus Pharmaceuticals: Top 10 Undervalued Nano Cap Stocks on TSX (ASP)theglobeandmail.com - January 16 at 5:19 PMAcerus Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 15 at 8:24 AMAcerus Announces Amendment to Promissory Note Due to Former Serenity Shareholdersfinance.yahoo.com - October 3 at 8:03 AMAcerus Pharmaceuticals to Initiate Strategic Review of Operationsmarketwatch.com - September 21 at 12:42 PMAcerus Announces Initiation of Strategic Reviewfinance.yahoo.com - September 21 at 7:42 AMAcerus Pharmaceuticals CFO resigns effective November 20, 2022seekingalpha.com - August 23 at 6:13 PMAcerus Pharmaceuticals Corporation (ASPCF) CEO Edward Gudaitis on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 14 at 4:08 PMAcerus Announces Amendments to Loan Facility and Promissory Note Due to Former Serenity Shareholdersfinance.yahoo.com - August 5 at 9:32 AMAcerus Announces Voting Results for the 2022 Annual Meetingfinance.yahoo.com - June 27 at 9:29 PMAcerus Pharmaceuticals increases loan facility to $37.94Mseekingalpha.com - June 24 at 8:32 AMAcerus Pharmaceuticals GAAP EPS of $0.00, revenue of $0.78Mseekingalpha.com - May 11 at 11:13 PMAcerus To Report Q1-2022 Financial Results And Host Investor Callfinance.yahoo.com - May 5 at 10:03 AMAcerus Announces Completion of Share Consolidationfinance.yahoo.com - April 26 at 8:11 PMAcerus Announces Share Consolidationfinance.yahoo.com - April 19 at 6:37 PMAcerus to acquire Florida-based Serenity in cash/stock dealseekingalpha.com - February 28 at 7:17 PMAcerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva(TM)stockhouse.com - February 28 at 8:11 AMAcerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™finance.yahoo.com - February 28 at 8:11 AM Get Acerus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASPCF and its competitors with MarketBeat's FREE daily newsletter. Email Address A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. ASPCF Media Mentions By Week ASPCF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ASPCF News Sentiment▼0.000.44▲Average Medical News Sentiment ASPCF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ASPCF Articles This Week▼00▲ASPCF Articles Average Week Get Acerus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASPCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BCTXF News Today GRI News Today ATNF News Today PBLA News Today NBSE News Today INM News Today PRFX News Today GLMD News Today QLGN News Today LSDI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ASPCF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acerus Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
